C

Cooper Companies Inc
LSE:0I3I

Watchlist Manager
Cooper Companies Inc
LSE:0I3I
Watchlist
Price: 94.41 USD 3.01% Market Closed
Market Cap: 468.2B USD
Have any thoughts about
Cooper Companies Inc?
Write Note

Net Margin
Cooper Companies Inc

10.1%
Current
20%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
10.1%
=
Net Income
392.3m
/
Revenue
3.9B

Net Margin Across Competitors

Country US
Market Cap 19.7B MXN
Net Margin
10%
Country JP
Market Cap 6.8T JPY
Net Margin
24%
Country CH
Market Cap 37.6B CHF
Net Margin
12%
Country DK
Market Cap 179.6B DKK
Net Margin
19%
Country US
Market Cap 15.8B USD
Net Margin
11%
Country CN
Market Cap 51.4B CNY
Net Margin
42%
Country CA
Market Cap 6.3B USD
Net Margin
-8%
Country KR
Market Cap 9.1T KRW
Net Margin
-358%
Country US
Market Cap 6.2B USD
Net Margin
29%
Country UK
Market Cap 4.5B GBP
Net Margin
7%
Country US
Market Cap 5.7B USD
Net Margin
9%
No Stocks Found

Cooper Companies Inc
Glance View

Market Cap
468.2B USD
Industry
Health Care

In the world of healthcare innovation, Cooper Companies Inc. etched its name as a significant player, specializing in creating products that enhance lives, particularly in the fields of vision care and women’s health. Established in 1958, Cooper Companies evolved to become a holding company operating through its two primary business units: CooperVision and CooperSurgical. CooperVision is renowned globally for its expertise in contact lenses, providing a diversified range of lenses to correct myopia, hyperopia, astigmatism, and presbyopia. By leveraging cutting-edge technology and a deep understanding of wearer needs, CooperVision caters to a wide spectrum of users, from daily disposables to specialty lenses, thus driving consistent revenue through the consumable nature of its products. CooperSurgical, on the other hand, focuses on solutions for women’s health, offering a gamut of medical instruments, devices, and diagnostics. This unit extends Cooper Companies' footprint into the realms of fertility products, contraception, and obstetrics. By addressing key segments of the women’s health market, CooperSurgical supports clinical needs across a woman’s lifespan. Revenue opportunities here arise from both its durable medical equipment and consumable products, which ensure a stream of repeat business as healthcare providers replenish their supplies. Together, these divisions enable Cooper Companies to not only secure a robust market position but also continuously explore new areas for growth and expansion within the broader healthcare industry.

0I3I Intrinsic Value
696.33 USD
Undervaluation 86%
Intrinsic Value
Price
C

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
10.1%
=
Net Income
392.3m
/
Revenue
3.9B
What is the Net Margin of Cooper Companies Inc?

Based on Cooper Companies Inc's most recent financial statements, the company has Net Margin of 10.1%.